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Key Clinical Message
Disseminated histoplasmosis and hemophagocytic lymphohistiocytosis show
overlapping features, which require careful contextual interpretation.
Histopathologic evaluation can potentially rapidly identify cases of possible
histoplasmosis. A high index of clinical suspicion, particularly in endemic areas
and in a setting of immunosuppression, is critical to appropriate diagnosis and
treatment.
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A 29-year-old man with a history of end-stage renal dis-
ease secondary to minimal change disease, status postre-
nal transplant 2 years prior, presented with a one-week
history of fever, night sweats, chills, generalized aches,
and diarrhea. His immunosuppressive regimen included
tacrolimus, cyclosporine, and prednisone. The patient
lives in Michigan and works as a truck driver with most
recent travel to Arizona and Texas. Following admission,
he was noted to be tachycardic and febrile (up to
40.1°C), but his physical examination was otherwise unre-
markable. CBC showed mild anemia (Hgb as low as
11.1 g/dL) and variable thrombocytopenia (platelets as
low as 115 k/lL). Imaging studies were significant for ill-
defined centrilobular groundglass opacities in the lungs,
although without any respiratory complaints or hypoxia
initially. PET/CT also noted hypermetabolic lymph nodes,
spleen (without splenomegaly), and a soft tissue mass in
the porta hepatis, raising the possibility of a post-trans-
plant lymphoproliferative disorder; however, a biopsy was
not performed during the admission based on the subse-
quent findings.
He was initially placed on empiric therapy with van-
comycin and piperacillin–tazobactam and over the next
5 days underwent an extensive workup including blood
and urine cultures; CMV, HIV, EBV, HHV6, parvovirus,
toxoplasma, adenovirus, and HSV PCR; Q fever, Bar-
tonella, Brucella, parvovirus and fungal serology; and
Clostridium difficile antigen and toxin and serum crypto-
coccal and urine Legionella antigen. These results were all
negative. Concurrently, he was found to have hyperfer-
ritinemia of 14,914 ng/mL (normal range 18–320 ng/mL)
and triglycerides 228 mg/dL, concerning for hemophago-
cytic lymphohistiocytosis (HLH). To evaluate for
hemophagocytosis, soluble CD25 was measured at
2291 U/mL, fibrinogen was 415 mg/dL, and a bone mar-
row biopsy was performed; NK-cell activity was not mea-
sured. The core biopsy showed normocellular bone
marrow with trilineage hematopoiesis.
A single histiocyte with oval-shaped organisms was
seen on the aspirate smear (Fig. 1A). The morphological
differential diagnosis included Histoplasma capsulatum,
Leishmania species, Candida glabrata, Blastomyces der-
matitidis, among others [1]. Grocott-methenamine silver
stain performed on the bone marrow core demonstrated
additional histiocytes containing multiple yeast forms
exhibiting narrow-based budding (Fig. 1B). Rare
hemophagocytes were noted (Fig. 1C). Based on these
findings, intravenous liposomal amphotericin was
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started. Subsequent urine Histoplasma antigen test results
(above the limit of quantification) and fungal blood
culture results returned, confirming a diagnosis of
H. capsulatum.
Disseminated histoplasmosis is predominantly seen in
immunosuppressed patients, including solid organ trans-
plant patients [2]. An association between hemophago-
cytic lymphohistiocytosis (HLH) and H. capsulatum
infection has been observed, commonly in the setting of
AIDS [3, 4]. The diagnostic criteria for HLH in the 2004
guidelines include fever, splenomegaly, cytopenias affect-
ing at least two of the three lineages, hypertriglyceridemia
and/or hypofibrinogenema, hemaphagocytosis in the bone
marrow spleen or lymph nodes, low/absent NK-cell activ-
ity, hyperferritinemia and high levels of sIL-2r [5]. The
patient met three of these (fever, elevated ferritin, and
rare hemophagocytosis), which was insufficient for diag-
nosis of HLH, although soluble CD25, triglycerides and
cytopenias did approach meeting criteria. HLH can be
seen either as a primary hereditary disorder or secondary
to a number of causes including infection (particularly
viral, e.g., EBV), malignancy, and rheumatologic disease.
It is important to note that hyperferritinemia alone is not
specific for HLH, as this finding in isolation can be seen
in the setting of inflammation and infection, even with
indolent course [6]. Histoplasma infection in particular
can cause elevated ferritin and fever without meeting
other criteria for HLH. It is also important to point out
that hemophagocytosis seen on bone marrow aspirate is
not specific to HLH [7, 8]. In a study by Riviere et al.
[8], hemophagocytosis was found in 39.4% of patients
where the diagnosis of HLH was suspected but ultimately
ruled out, as in this case.
This case demonstrates an instance where the bone
marrow biopsy was particularly useful in early detection
of the patient’s infection, as some of the confirmatory
assays require more extended periods of time to result.
Although bronchoalveolar lavage (BAL) and respiratory
cultures were not performed in the current case,
histopathologic evaluation of these samples could also
potentially have yielded similarly analogous information.
A high index of clinical suspicion for infection in poten-
tial patients with HLH who are immunosuppressed is
necessary, both in the clinical and pathologic practice,
especially in endemic areas. This patient was continued
on intravenous liposomal amphotericin followed by
voriconazole. He exhibited complete response with imme-
diate reduction in fever and resolution of all imaging
abnormalities and symptoms.
In subsequent monitoring, the ferritin initially
increased to >16,500 ng/mL in the 2 days prior to bone
marrow biopsy and decreased to 3602 ng/mL 5 days after
the bone marrow biopsy was performed with no addi-
tional follow-up.
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Figure 1. A. Wright-Giemsa stained bone marrow aspirate showing multiple intracellular organisms within a histiocyte. B. Grocott methenamine
stain highlights additional organisms on the core biopsy. C. Example of hemophagocytosis in bone marrow aspirate.
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